According to the company tagline “Personalized Treatment Surveillance. Better Outcomes.” CareDX, Inc. is a molecular diagnostic company which is known for its AlloMap service that monitors patients with heart transplants. Current focus is on expanding the AlloMap line of blood-test products with cfDNA for Heart and cfDNA Kidney – potentially changing the lives of millions of transplant patients worldwide. Key of the company is ‘gene expression profiling,’ using the best of semiconductor industry to analyze blood cells on a molecular level, in order to identify gene activity in various types of blood cells. By building patient maps, doctors can research and predict how a patient is reacting to treatment, inflammation
